Multiplan CORP

Market Movers (8-K)

Claritev Corporation announced the passing of Board Director John Prince on July 6, 2026, who was a member of the Audit Committee.
Claritev Corporation issues a statement clarifying its cooperation with a DOJ antitrust investigation into health insurance, following recent media reports.
Claritev Corporation announced its first quarter 2026 financial results, reporting revenue growth and an increase in Adjusted EBITDA, while also detailing a net loss and increased cash used in operations.
Claritev Corporation stockholders approved the election of four directors and an increase of 2.375 million shares for the 2020 Omnibus Incentive Plan.
Claritev Corporation's 2026 Investor Day presentation outlines a strategic roadmap for sustained growth, digital transformation, and AI integration, projecting significant revenue and EBITDA increases by 2030.
Claritev Corporation announced robust fourth quarter and full-year 2025 financial results, including a return to revenue growth and improved profitability, alongside the approval of a new $75 million share repurchase program.
Better than expected

Quarterly Earnings (10-Q)

Claritev Corporation reported a 5.8% increase in revenue for Q1 2026, reaching $244.7 million, but experienced a wider net loss of $73.6 million.
Worse than expected
Claritev Corporation reports improved net loss and operating income in Q3 2025, driven by revenue growth and absence of goodwill impairment, while navigating a major debt refinancing and ERP system implementation.
Capital raise
Better than expected
Claritev Corporation reported a narrower net loss and increased revenues in Q2 2025, driven by growth in Network-Based Services and the absence of prior year's goodwill impairment.
Delay expected
Better than expected
Capital raise
Claritev Corporation's Q1 2025 results show a slight revenue decrease and a net loss, but improvements in operating income compared to the previous year due to decreased impairment losses.
Worse than expected
MultiPlan Corporation's Q3 2024 results reveal a significant net loss driven by goodwill impairment and a decrease in revenues, particularly in Network-Based Services.
Worse than expected
Capital raise
MultiPlan Corporation's Q2 2024 results were significantly impacted by a goodwill impairment charge and a cyberattack that disrupted claims processing, leading to a substantial net loss.
Worse than expected

Annual Reports (10-K)

Claritev Corporation reported a 3.7% increase in total revenue for 2025, reaching $965.4 million, alongside a significant reduction in net loss to $284.3 million, while addressing substantial indebtedness and internal control weaknesses.
Claritev Corporation, formerly MultiPlan, released its 2024 annual results, highlighting a rebranding effort and a strategic plan focused on technology and data insights.
Worse than expected
MultiPlan Corporation's 10-K filing provides a comprehensive overview of its financial performance, strategic initiatives, and risk factors for the fiscal year ended December 31, 2023.
Worse than expected

Insider Trading (Form 4)

Claritev Corp's SVP, Chief Accounting Officer, Albinson Brock, received a grant of 3,649 restricted stock units on June 30, 2026.
Carol Nutter, SVP and Chief People Officer of Claritev Corp, sold 875 shares of Class A common stock on June 9, 2026.
Michael Kim, EVP and Chief Digital Officer of Claritev Corp, acquired 3,000 shares of Class A common stock.
Director John Prince acquired 10,000 shares of Claritev Corp Class A common stock on May 19, 2026, for $16 per share.
Director Julie D. Klapstein acquired 8,977 restricted stock units in Claritev Corp as part of a standard equity grant.
Director Michael Stuart Klein acquired 8,977 restricted stock units in Claritev Corp as part of a standard equity grant.

Proxy Statements (Def-14A)

Claritev Corporation's definitive proxy statement highlights a return to positive revenue growth, improved Adjusted EBITDA, and strengthened free cash flow in 2025, alongside strategic expansion and digital transformation efforts.
Capital raise
Better than expected
Claritev Corporation has filed a definitive proxy statement with the SEC.
Claritev Corporation is asking stockholders to approve an amendment to its 2020 Omnibus Incentive Plan to increase the number of shares available for grant.
Worse than expected
Multiplan Corporation has filed definitive additional materials related to its upcoming special meeting with the Securities and Exchange Commission.
MultiPlan Corporation is asking stockholders to approve a reverse stock split proposal, ranging from 1/40 to 1/15, to increase its stock price and meet NYSE continued listing requirements.
MultiPlan Corporation has filed a definitive proxy statement with the SEC, indicating no fee is required for the filing.

Schedule 13D - Activist Investments

Hellman & Friedman entities have reduced their beneficial ownership in Claritev Corporation to 23.5% through a secondary offering of 1.5 million shares at $51.50 per share.
Affiliates of private equity firm Leonard Green & Partners have sold a significant portion of their Class A Common Stock in MultiPlan Corp, reducing their beneficial ownership to below 5% and filing an exit amendment to their Schedule 13D.
Worse than expected

Schedule 13G - Passive Investments

Arini Capital Management and its affiliates have disclosed a beneficial ownership of 7.64% in Claritev Corp's common stock.
A group of Ares Management entities, including ASOF II Holdings I, L.P. and ASOF II A (DE) Holdings I, L.P., have filed an amended Schedule 13G disclosing a combined passive beneficial ownership of 11.5% in MultiPlan Corp's Class A Common Stock.
Ares Management Corporation and its affiliated entities have disclosed a beneficial ownership of 5.5% of MultiPlan Corp.'s Class A Common Stock, as reported in a recent Schedule 13G filing with the SEC.